Name: Liminatus Pharma, Inc. (LIMN) Cash Flow Statement
Creator: FinSpry

Liminatus Pharma Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Liminatus Pharma, Inc. (LIMN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Operating Activities
Net Income	-2.90	-4.98	-2.93	-5.61
Depreciation & Amortization	0.00	0.00	0.00	0.00
Change in Working Capital	-0.04	1.64	1.16	3.05
Change in Accounts Receivable	0.05	0.00	0.00	0.00
Change in Accounts Payable	0.00	0.43	0.11	0.04
Change in Other Working Capital	-0.09	1.21	0.90	3.01
Other Operating Activities	-0.16	0.00	0.90	1.50
Net Cash from Operating Activities	-3.11	-3.35	-0.87	-0.17
Investing Activities
Purchases of Investments	-0.19	0.00	0.00	0.00
Sales/Maturities of Investments	2.16	0.00	0.00	0.00
Net Cash from Investing Activities	1.97	-0.82	0.00	0.00
Financing Activities
Debt Repayment	2.85	-3.86	-7.03	0.00
Common Stock Issued	0.00	0.00	4.20	0.00
Common Stock Repurchased	-1.80	0.00	-0.70	0.00
Net Cash from Financing Activities	1.05	-0.45	5.92	0.00
Summary
Effect of Forex Changes on Cash	0.74	0.00	0.00	0.00
Net Change in Cash	0.65	-4.61	5.05	-0.17
Cash at Beginning of Period	0.16	5.05	0.00	0.00
Cash at End of Period	0.80	0.43	5.05	0.00
Free Cash Flow	-3.11	-3.35	-0.87	0.00
Supplemental Disclosures
Interest Paid	0.00	0.00	0.50	0.00